Gene Delivery Platforms

다국어 초록 (Multilingual Abstract)

One of the key challenges in the experimental and therapeutic use of gene delivery agents is the development of methods that can efficiently deliver nucleic acids into living systems. During the past decade, the development of effective and safe gene delivery systems has been intensively investigated. This review summarizes the current state of gene delivery methods based on viral and non-viral agents.

참고문헌 (Reference)

1 Iijima, S, "elical microtubules of graphitic carbon" 354 : 56-58, 1991

2 Lundstrom, K., "Viral and non-viral vectors in gene therapy: Technology development and clinical trials" 2 : 471-486, 2003

3 Gardlik, R., "Vectors and delivery systems in gene therapy" 11 : 110-121, 2005

4 Huh, M. S., "Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice" ELSEVIER SCIENCE BV 144 (144): 134-143, 2010

5 Meir, Y. J., "Transposon-based vector systems for gene therapy clinical trials: challenges and considerations" 34 : 565-579, 2011

6 Goodman, C. M., "Toxicity of gold nanoparticles functionalized with cationic and anionic side chains" 15 : 897-900, 2004

7 Talaei, F., "Thiolated chitosan nanoparticles as a delivery system for antisense therapy: Evaluation against EGFR in T47D breast cancer cells" 6 : 1963-1975, 2011

8 Prasad, T. K., "The role of plasmid constructs containing the SV40 DNA nuclear-targeting sequence in cationic lipid-mediated DNA delivery" 10 : 203-215, 2005

9 El Ouahabi, A., "The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids" 414 : 187-192, 1997

10 Yao, H., "The gene transfection efficiency of a folate-PEI600-cyclodextrin nanopolymer" 30 : 5793-5803, 2009

11 Hashida, M., "Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine)" 53 : 301-310, 1998

12 Peer, D., "Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target" 319 : 627-630, 2008

13 Brust, M., "Synthesis of Thiol-derivatized gold nanoparticles in a 2- phase liquid-liquid system" 801-802, 1994

14 Guo, Q. F., "Synthesis and properties of a novel biodegradable poly(ester amine) copolymer based on poly(L-lactide) and low molecular weight polyethylenimine for gene delivery" 6 : 1641-1649, 2011

15 Hacein-Bey-Abina, S., "Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy" 346 : 1185-1193, 2002

16 Yu, S. F., "Selfinactivating retroviral vectors designed for transfer of whole genes into mammalian cells" 83 : 3194-3198, 1986

17 Wright, J. F., "Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector" 6 : 174-178, 2003

18 Semple, S. C., "Rational design of cationic lipids for siRNA delivery" 28 : 172-176, 2010

19 Zimmermann, T. S., "RNAi-mediated gene silencing in nonhuman primates" 441 : 111-114, 2006

20 Belting, M., "Protective role for proteoglycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro" 342 : 281-286, 1999

21 Weinberg, J. B., "Productive human immunodeficiency virus type 1 (HIV- 1) infection of nonproliferating human monocytes" 174 : 1477-1482, 1991

22 Xia, T., "Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs" 3 : 3273-3286, 2009

23 Zhu, S. G., "Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides" 39 : 179-187, 2004

24 Lee, H., "PEGylated polyethyleneimine grafted silica nanoparticles: enhanced cellular uptake and efficient siRNA delivery" SPRINGER HEIDELBERG 400 (400): 535-545, 2011

25 Bottini, M., "PEG-modified carbon nanotubes in biomedicine: Current status and challenges ahead" 12 : 3381-3393, 2011

26 Dokka, S., "Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes" 17 : 521-525, 2000

27 Rosi, N. L., "Oligonucleotide-modified gold nanoparticles for intracellular gene regulation" 312 : 1027-1030, 2006

28 Giljohann, D. A., "Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles" 7 : 3818-3821, 2007

29 Gao, X., "Nonviral gene delivery: What we know and what is next" 9 : 92-104, 2007

30 Filion, M. C., "Major limitations in the use of cationic liposomes for DNA delivery" 162 : 159-170, 1998

31 Scherer, F., "Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo" 9 : 102-109, 2002

32 Chen, G. H., "MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression" 30 : 1962-1970, 2009

33 Carpenter, D. E., "Long-term expression of a foreign gene from a unique position in the latent herpes simplex virus genome" 7 : 1447-1454, 1996

34 Murphy, J. E., "Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin" 94 : 13921-13926, 1997

35 Spagnou, S., "Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA" 43 : 13348-13356, 2004

36 Schmid, G., "Large clusters and colloids - metals in the embryonic state" 92 : 1709-1727, 1992

37 Ryou, S. M., "Inhibition of xenograft tumor growth in mice by gold nanoparticle-assisted delivery of short hairpin RNAs against Mcl-1L" ELSEVIER SCIENCE BV 156 (156): 89-94, 2011

38 Guissouma, H., "In vivo siRNA delivery to the mouse hypothalamus confirms distinct roles of TR beta isoforms in regulating TRH transcription" 406 : 240-243, 2006

39 Ofek, P., "In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers" 24 : 3122-3134, 2010

40 Yang, N. S., "In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment" 87 : 9568-9572, 1990

41 Fischer, D., "In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis" 24 : 1121-1131, 2003

42 Yang, Y., "Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo" 3 : 137-144, 1996

43 Taetz, S., "Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells" 19 : 103-116, 2009

44 Yang, J., "Hollow silica nanocontainers as drug delivery vehicles" AMER CHEMICAL SOC 24 (24): 3417-3421, 2008

45 Manservigi, R., "HSV Recombinant Vectors for Gene Therapy" 4 : 123-156, 2010

46 Pan, Y., "Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage" 5 : 2067-2076, 2009

47 Connor, E. E., "Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity" 1 : 325-327, 2005

48 Sandhu, K. K., "Gold nanoparticle-mediated transfection of mammalian cells" 13 : 3-6, 2002

49 Rosenberg, S. A., "Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction" 323 : 570-578, 1990

50 Dobson, J., "Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery" 13 : 283-287, 2006

51 Hart, S. L., "Gene delivery and expression mediated by an integrin-binding peptide" 2 : 552-554, 1995

52 Ji, A. M., "Functional gene silencing mediated by chitosan/ siRNA nanocomplexes" 20 : 405103-, 2009

53 Kim, Y. J., "Enhanced protein-mediated binding between oligonucleotide–gold nanoparticle composites and cell surfaces: Co-transport of proteins and composites" 22 : 25036-25041, 2012

54 Guo, S., "Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte" 4 : 5505-5511, 2010

55 Mukherjee, S., "Endocytosis. Physiol. Rev" 77 : 759-803, 1997

56 Friend, D. S., "Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes" 1278 : 41-50, 1996

57 Heller, L. C., "Electroporation for targeted gene transfer" 2 : 255-268, 2005

58 Wendtner, C. M., "Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors" 100 : 1655-1661, 2002

59 Midoux, P., "Efficient gene transfer by histidylated polylysine/pDNA complexes" 10 : 406-411, 1999

60 Follenzi, A., "Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors" 13 : 243-260, 2002

61 Li, S., "Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors" 276 : 796-804, 1999

62 Zong, C., "Dual-emission fluorescent silica nanoparticle-based probe for ultrasensitive detection of Cu2+" 83 : 3126-3132, 2011

63 Blau, S., "Drug targeting by surface cationization" 17 : 425-465, 2000

64 Kumar, S., "Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties" 3 : 314-320, 2008

65 Blessing, T., "Different strategies for formation of pegylated EGFconjugated PEI/DNA complexes for targeted gene delivery" 12 : 529-537, 2001

66 Lu, Z. X., "Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumortargeted therapy" 6 : 1661-1673, 2011

67 Ryou, S. M., "Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier" ACADEMIC PRESS INC ELSEVIER SCIENCE 398 (398): 542-546, 2010

68 Kircheis, R., "Coupling of cellbinding ligands to polyethylenimine for targeted gene delivery" 4 : 409-418, 1997

69 Loisel, S., "Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes" 12 : 685-696, 2001

70 Barichello, J. M., "Complexation of siRNA and pDNA with cationic liposomes: The important aspects in lipoplex preparation" 605 : 461-472, 2010

71 Rainov, N. G., "Clinical trials with retrovirus mediated gene therapy--what have we learned?" 65 : 227-236, 2003

72 Frankel, A. D., "Cellular uptake of the tat protein from human immunodeficiency virus" 55 : 1189-1193, 1988

73 Pierschbacher, M. D., "Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule" 309 : 30-33, 1984

74 Kong, W. H., "Cationic Lipid-Coated Gold Nanoparticles as Efficient and Non-Cytotoxic Intracellular siRNA Delivery Vehicles" SPRINGER/PLENUM PUBLISHERS 29 (29): 362-374, 2012

75 Li, J., "Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery" 142 : 416-421, 2010

76 Podesta, J. E., "Antitumor activity and prolonged survival by carbon-nanotube- mediated therapeutic siRNA silencing in a human lung xenograft model" 5 : 1176-1185, 2009

77 O'Brien, J., "An improved method of preparing microcarriers for biolistic transfection" 10 : 12-15, 2002

78 Bett, A. J., "An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3" 91 : 8802-8806, 1994

79 Boussif, O., "A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine" 92 : 7297-7301, 1995

80 Radu, D. R., "A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent" 126 : 13216-13217, 2004

81 Fischer, D., "A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: Effect of molecular weight on transfection efficiency and cytotoxicity" 16 : 1273-1279, 1999

82 Namiki, Y., "A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery" 4 : 598-606, 2009

83 Kim, J. H., "A functionalized gold nanoparticles-assisted universal carrier for antisense DNA" ROYAL SOC CHEMISTRY 46 (46): 4151-4153, 2010

84 Chia, M. C., "A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy" 9 : 804-817, 2004

85 Mirkin, C. A., "A DNA-based method for rationally assembling nanoparticles into macroscopic materials" 382 : 607-609, 1996